China Universal Asset Management Co., Ltd. Cullinan Oncology, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,996 shares of CGEM stock, worth $145,555. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,996
Previous 8,996
-0.0%
Holding current value
$145,555
Previous $153,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding CGEM
# of Institutions
118Shares Held
42.8MCall Options Held
12.6KPut Options Held
4.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$124 Million21.33% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$55.2 Million15.23% of portfolio
-
Bvf Inc San Francisco, CA3.2MShares$51.7 Million1.63% of portfolio
-
Blue Owl Capital Holdings LP New York, NY2.92MShares$47.3 Million13.21% of portfolio
-
Franklin Resources Inc San Mateo, CA2.7MShares$43.6 Million0.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $738M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...